Table of Contents page: European Journal of Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Editorial board

Published in issue: May 2009

ii

EJC NEWS, ISSUE 8, 2009

Published in issue: May 2009

p1325-1329

Positioning pemetrexed in the treatment of ovarian cancer

Jonathan A. Ledermann,

Justin Stebbing

Published online: March 05, 2009

p1330-1332

C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation

Elena De Mattia,
Giuseppe Toffoli

Published online: January 14, 2009

p1333-1351

Nitric oxide delivery to cancer: Why and how?

Pierre Sonveaux,
Bénédicte F. Jordan,
Bernard Gallez,
Olivier Feron

Published online: January 19, 2009

p1352-1369

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal

Wendy H. Oldenmenger,
Peter A.E. Sillevis Smitt,
Silvia van Dooren,
Gerrit Stoter,
Carin C.D. van der Rijt

Published online: February 09, 2009

p1370-1380

Axillary metastases in breast cancer patients with negative sentinel nodes: A follow-up of 3548 cases

Umberto Veronesi,
Viviana Galimberti,
Giovanni Paganelli,
...
Luciana De Brito Lima,
Marco Tullii,
Stefano Zurrida

Published online: January 07, 2009

p1381-1388

Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis

Ping Gu,
Yi-Zhuo Zhao,
Li-Yan Jiang,
Wei Zhang,
Yu Xin,
Bao-Hui Han

Published online: January 05, 2009

p1389-1396

Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation

Konstantin J. Dedes,
Klazien Matter-Walstra,
Matthias Schwenkglenks,
...
Daniel Fink,
Peter Brauchli,
Thomas D. Szucs

Published online: January 15, 2009

p1397-1406

Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: Correlation with clinical parameters and outcome

Roger Mouawad,
Jean-Philippe Spano,
Eva Comperat,
Frederique Capron,
David Khayat

Published online: January 21, 2009

p1407-1414

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer

Ignace Vergote,
Hilary Calvert,
Marek Kania,
Christopher Kaiser,
Annamaria Hayden Zimmermann,
Jalid Sehouli

Published online: January 27, 2009

p1415-1423

Improving the efficacy of cancer immunotherapy

J. Copier,
A.G. Dalgleish,
C.M. Britten,
...
J. Talmadge,
H. Zwierzina,
L. Håkansson

Published online: January 23, 2009

p1424-1431

Evaluation of alternative prognostic stratifications by prediction accuracy measures on individual survival with application to childhood leukaemia

Paola De Lorenzo,
Laura Antolini,
Maria Grazia Valsecchi

Published online: February 17, 2009

p1432-1437

Glutathione S-transferase P1 gene polymorphism associated with gastric cancer among Caucasians

Yong Zhou,
Ni Li,
Wen Zhuang,
...
Liang Du,
Mao-Ling Wei,
Xiao-Ting Wu

Published online: January 21, 2009

p1438-1442

MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls

Jian-Ling Bai,
Ming-Hua Zheng,
Xian Xia,
Monica Ter-Minassian,
Yong-Ping Chen,
Feng Chen

Published online: February 17, 2009

p1443-1449

Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland

L. Sharp,
A.-E. Carsin,
D.P. Cronin-Fenton,
D. O’Driscoll,
H. Comber

Published online: March 06, 2009

p1450-1459

Prevalence of patients with colorectal cancer requiring follow-up or active treatment

Marion Chauvenet,
Côme Lepage,
Valérie Jooste,
Vanessa Cottet,
Jean Faivre,
Anne-Marie Bouvier

Published online: February 13, 2009

p1460-1465

Cdc2 as prognostic marker in stage UICC II colon carcinomas

Alexander Meyer,
Susanne Merkel,
Wolfgang Brückl,
...
Valentina Campean,
Werner Hohenberger,
Roland S. Croner

Published online: February 17, 2009

p1466-1473

Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent

Girieca Lorusso,
Nicola Vannini,
Ilaria Sogno,
...
Spiridione Garbisa,
Douglas M. Noonan,
Adriana Albini

Published online: February 17, 2009

p1474-1484

A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR

Lucia Perez-Cabornero,
Eladio Velasco,
Mar Infante,
...
Lara Hernández,
Cristina Miner,
Mercedes Duran

Published online: March 02, 2009

p1485-1493

Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera

Fayaz Malik,
Ajay Kumar,
Shashi Bhushan,
...
Krishan A. Suri,
Ghulam N. Qazi,
Jaswant Singh

Published online: March 09, 2009

p1494-1509

The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer

Donal J. Brennan,
Sara Ek,
Emma Doyle,
...
Karin Jirstrom,
Colm O’Herlihy,
Carl A.K. Borrebaeck

Published online: March 09, 2009

p1510-1517

$A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib$

A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib

Michael J. Donovan,
Angeliki Kotsianti,
Valentina Bayer-Zubek,
...
F. Anthony Greco,
John D. Hainsworth,
Dinah V. Parums

Published online: March 09, 2009

p1518-1526

Calendar

Published in issue: May 2009

I-IV

May 2009

Editorial board

EJC NEWS, ISSUE 8, 2009

Editorial

Positioning pemetrexed in the treatment of ovarian cancer

Reviews

C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation

Nitric oxide delivery to cancer: Why and how?

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal

Clinical oncology

Axillary metastases in breast cancer patients with negative sentinel nodes: A follow-up of 3548 cases

Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis

Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation

Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: Correlation with clinical parameters and outcome

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer

Improving the efficacy of cancer immunotherapy

Paediatric oncology

Evaluation of alternative prognostic stratifications by prediction accuracy measures on individual survival with application to childhood leukaemia

Epidemiology and cancer prevention

Glutathione S-transferase P1 gene polymorphism associated with gastric cancer among Caucasians

MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls

Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland

Prevalence of patients with colorectal cancer requiring follow-up or active treatment

Experimental oncology

Cdc2 as prognostic marker in stage UICC II colon carcinomas

Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent

A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR

Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera

The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer

A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib

Calendar